RELX Plc - ADR
RELX
Get informed when a big investor buys or sells
+ FollowEarnings Call Q4 2023
February 15, 2024 - AI Summary
Exclusive for Stockcircle Pro members
Sign up
Current Fair Value
53.9% upsideUndervalued by 53.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $59.35 Billion |
|---|---|
| Enterprise Value | $66.54 Billion |
| Dividend Yield | $0.92 (2.71%) |
| Earnings per Share | $1.1 |
| Beta | 0.25 |
| Outstanding Shares | 1,819,000,000 |
Return
| Return on Equity | 169.03% |
|---|---|
| Return on Assets | 27.10% |
| Return on Invested Capital | 66.81% |
Valuation & Multiples
| P/E Ratio | 21.95 |
|---|---|
| PEG | 156.31 |
| Price to Sales | 3.37 |
| Price to Book Ratio | 33.74 |
| Enterprise Value to Revenue | 3.5 |
| Enterprise Value to EBIT | 11.38 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 3.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3639▲ 36.39% |
|---|---|
| Total Calls | 581,600▲ 79.17% |
| Total Puts | 211,625▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.65%▲ 0.31% |
|---|---|
| Total Invested | $2.83B▼ 13.75% |
| Investors Holding | 453▼ 37.00% |
ESG Score
No data
About RELX Plc
Relevant Senate Committees
Controls taxation and trade policy, directly impacting RELX's corporate profitability, global operations, and the overall economic landscape affecting its diverse customer base.
Regulates FDA and NIH; this directly impacts RELX's Scientific, Technical & Medical (STM) information division through drug approval oversight and scientific research funding.
Oversees intellectual property and antitrust laws. Intellectual property is fundamental to a publisher, and antitrust scrutiny is critical for large information providers like RELX.
Regulates the financial system (Fed, SEC); RELX's LexisNexis Risk Solutions provides critical data and analytics to financial institutions, making regulatory changes highly impactful.
Vast jurisdiction over interstate commerce, FTC (consumer protection, antitrust), and privacy laws directly impacts RELX's data collection, usage, and information services, especially for 'Big Tech' issues.